Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

410
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
410
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

218
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
218
Survival Tree01:19

Survival Tree

131
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
131
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

172
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
172
Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

β-Catenin regulates distinct pathways from YAP and suppresses ONECUT1 to drive hepatoblastoma development in mice and humans.

Hepatology (Baltimore, Md.)·2025
Same author

Pathogenesis and Systemic Treatment of Hepatocellular Carcinoma: Current Status and Prospects.

Molecular cancer therapeutics·2024
Same author

Promising first-line immuno-combination therapies for unresectable hepatocellular carcinoma: A cost-effectiveness analysis.

Cancer medicine·2024
Same author

Nivolumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: a cost-effectiveness analysis.

Cost effectiveness and resource allocation : C/E·2023
Same author

Circulating gamma-glutamyl transpeptidase and risk of pancreatic cancer: A prospective cohort study in the UK Biobank.

Cancer medicine·2022
Same author

First-line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component.

Cancer medicine·2021

Related Experiment Video

Updated: Aug 12, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

833

Multiview Deep Forest for Overall Survival Prediction in Cancer.

Qiucen Li1, Zedong Du2, Zhikui Chen1

  • 1Dalian University of Technology, School of Software, China.

Computational and Mathematical Methods in Medicine
|January 30, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces a novel Multiview Deep Forest (MVDF) model to accurately predict overall survival (OS) in cancer patients. The MVDF method effectively handles complex data and reduces overfitting, improving cancer prognosis prediction.

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

169

Related Experiment Videos

Last Updated: Aug 12, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

833
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

169

Area of Science:

  • Oncology
  • Machine Learning
  • Bioinformatics

Background:

  • Overall survival (OS) is a critical metric in cancer treatment and prognosis.
  • Existing machine learning methods struggle with multiview data and overfitting in OS prediction.

Purpose of the Study:

  • To develop an advanced machine learning model for accurate cancer overall survival prediction.
  • To address the challenges of multiview data integration and overfitting in survival analysis.

Main Methods:

  • Proposed a Multiview Deep Forest (MVDF) model integrating features from multiple data views.
  • Employed integrated learning and multiple kernel learning for feature fusion.
  • Utilized a gradient boost forest based on information bottleneck theory to minimize redundancy and prevent overfitting.
  • Implemented a pruning strategy for cascaded forests to mitigate outlier impact.

Main Results:

  • The MVDF model demonstrated superior performance in predicting overall survival compared to existing methods.
  • Experiments conducted on clinical and public datasets validated the model's effectiveness.
  • The proposed methods successfully handled multiview data and reduced overfitting.

Conclusions:

  • The Multiview Deep Forest (MVDF) model offers a robust solution for cancer overall survival prediction.
  • MVDF's ability to manage multiview data and prevent overfitting enhances its clinical applicability.
  • This approach advances the field of machine learning in cancer prognosis.